Author:
Rathinaraj Benjamin Stephen,de Lima Fabio
Abstract
Biomarkers have shown great promise over the past decade the process of drug development more effective and have become an integral part of diagnosis of diseases. Biosensors were integrated with biomarker detection and point-of-care detection for signal amplification, high specificity and sensitivity, rapid response time, low cost, simplicity and multi-analytical testing. In order to detect more sensitively, these particular biomarkers have been explored with the possibility of real-time measurements in order to develop simple and compact systems which can analyze complex specimens. Various biosensors including electrochemical biosensors have recently been developed based on disease-specific biomarkers in the diagnosis of cancer disease. The main objective of the book chapter is to review research with new materials/methods in electrochemical biosensing techniques to detection of breast cancer biomarkers and evaluating latest techniques for detection of important analytes in real samples. In this book chapter, the recent development of electrochemical biosensors of breast cancer biomarkers will be reviewed. Furthermore, recent and future trend application of breast cancer biomarkers will be discussed.
Reference58 articles.
1. WHO. WHO Cancer Fact Sheet 2018. 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
2. WHO. WHO Breast cancer. WHO. 2017. Available from: https://www.who.int/cancer/prevention/diagnosis-screening/breast-cancer/en/
3. Wei PL, Lee LT, Tseng LM, Huang KW. Validation of assaying carcinoembryonic antigen in human serum by using immunomagnetic reduction. Scientific Reports. 2018;8(1):10002
4. Rizwan M, Elma S, Lim SA, Ahmed MU. AuNPs/CNOs/SWCNTs/chitosan-nanocomposite modified electrochemical sensor for the label-free detection of carcinoembryonic antigen. Biosensors and Bioelectronics. 2018;107:211-217
5. Gao Y-S, Zhu X-F, Xu J-K, Lu L-M, Wang W-M, Yang T-T, et al. Label-free electrochemical immunosensor based on Nile blue A-reduced graphene oxide nanocomposites for carcinoembryonic antigen detection. Analytical Biochemistry. 2016;500:80-87
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cancer Biology;Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective;2023-03-05
2. Detection of Cancer Biomarker by Advanced Biosensor;Targeted Cancer Therapy in Biomedical Engineering;2023
3. Recent Advances in Designing Porous Carbon Nanomaterial Based for Electrochemical Biosensing Prostate Cancer;Materials Horizons: From Nature to Nanomaterials;2023